Sean Dodge
Stock Analyst at BMO Capital
(2.07)
# 2,956
Out of 5,182 analysts
162
Total ratings
36.21%
Success rate
-4.04%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Market Perform | $460 → $400 | $421.37 | -5.07% | 2 | Apr 24, 2026 | |
| HCSG Healthcare Services Group | Maintains: Market Perform | $22 → $24 | $21.70 | +10.60% | 15 | Apr 23, 2026 | |
| HQY HealthEquity | Upgrades: Outperform | $85 → $105 | $83.47 | +25.79% | 14 | Apr 9, 2026 | |
| PHR Phreesia | Maintains: Outperform | $32 → $14 | $9.62 | +45.53% | 17 | Mar 31, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Outperform | $100 → $130 | $103.21 | +25.96% | 4 | Mar 26, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Outperform | $11 → $10 | $6.75 | +48.15% | 2 | Mar 20, 2026 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $18 | $14.72 | +22.28% | 2 | Mar 6, 2026 | |
| TDOC Teladoc Health | Maintains: Market Perform | $8 → $5 | $5.85 | -14.53% | 18 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $45 → $54 | $45.23 | +19.39% | 2 | Feb 26, 2026 | |
| WAY Waystar Holding | Maintains: Outperform | $47 → $30 | $25.70 | +16.73% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Outperform | $24 | $15.81 | +51.80% | 12 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $48.57 | -17.64% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $120 | $98.14 | +22.27% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $3.47 | +101.73% | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $163.84 | +58.69% | 7 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $9 | $6.24 | +44.23% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $300 | $160.45 | +86.97% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $7.27 | +10.04% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $24.41 | +22.90% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $55 | $24.66 | +123.03% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $6 | $1.37 | +337.96% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $88 | $25.32 | +245.58% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $7 → $6 | $6.41 | -6.40% | 11 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $25.72 | -45.57% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.28 | +338.60% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $186.49 | -82.30% | 1 | Sep 14, 2022 |
Medpace Holdings
Apr 24, 2026
Maintains: Market Perform
Price Target: $460 → $400
Current: $421.37
Upside: -5.07%
Healthcare Services Group
Apr 23, 2026
Maintains: Market Perform
Price Target: $22 → $24
Current: $21.70
Upside: +10.60%
HealthEquity
Apr 9, 2026
Upgrades: Outperform
Price Target: $85 → $105
Current: $83.47
Upside: +25.79%
Phreesia
Mar 31, 2026
Maintains: Outperform
Price Target: $32 → $14
Current: $9.62
Upside: +45.53%
ICON Public Limited Company
Mar 26, 2026
Upgrades: Outperform
Price Target: $100 → $130
Current: $103.21
Upside: +25.96%
Aveanna Healthcare Holdings
Mar 20, 2026
Maintains: Outperform
Price Target: $11 → $10
Current: $6.75
Upside: +48.15%
Omada Health
Mar 6, 2026
Maintains: Outperform
Price Target: $27 → $18
Current: $14.72
Upside: +22.28%
Teladoc Health
Feb 26, 2026
Maintains: Market Perform
Price Target: $8 → $5
Current: $5.85
Upside: -14.53%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $45 → $54
Current: $45.23
Upside: +19.39%
Waystar Holding
Feb 18, 2026
Maintains: Outperform
Price Target: $47 → $30
Current: $25.70
Upside: +16.73%
Jan 9, 2026
Reinstates: Outperform
Price Target: $24
Current: $15.81
Upside: +51.80%
Nov 13, 2025
Initiates: Outperform
Price Target: $40
Current: $48.57
Upside: -17.64%
Nov 13, 2025
Initiates: Market Perform
Price Target: $120
Current: $98.14
Upside: +22.27%
Nov 13, 2025
Initiates: Outperform
Price Target: $7
Current: $3.47
Upside: +101.73%
Nov 13, 2025
Initiates: Outperform
Price Target: $260
Current: $163.84
Upside: +58.69%
Nov 13, 2025
Initiates: Market Perform
Price Target: $9
Current: $6.24
Upside: +44.23%
Nov 13, 2025
Initiates: Market Perform
Price Target: $300
Current: $160.45
Upside: +86.97%
Nov 13, 2025
Initiates: Outperform
Price Target: $8
Current: $7.27
Upside: +10.04%
Nov 13, 2025
Initiates: Outperform
Price Target: $30
Current: $24.41
Upside: +22.90%
Nov 13, 2025
Initiates: Market Perform
Price Target: $55
Current: $24.66
Upside: +123.03%
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $1.37
Upside: +337.96%
Feb 26, 2025
Maintains: Outperform
Price Target: $75 → $88
Current: $25.32
Upside: +245.58%
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $6.41
Upside: -6.40%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $25.72
Upside: -45.57%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.28
Upside: +338.60%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $186.49
Upside: -82.30%